Men who use AndroGel and other low-T therapy medications may be more likely to experience dangerous cardiovascular complications, including stroke. Since March 2015, the manufacturers of prescription testosterone treatments have been required to include warnings regarding a possible increased risk of stroke on their product labels.
Thousands of plaintiffs have filed lawsuits over testosterone-related strokes, heart attacks and other cardiovascular problems allegedly associated with the use of AndroGel and other low-T therapies. If you or a man close to you suffered similar complications while using one of these mediations, please contact Bernstein Liebhard LLP at (888) 994-5118 to learn more about the legal options available to you.
A number of testosterone replacement drugs have been approved to treat men who suffer from hypogonadism (low testosterone) related to an underlying medical condition, such as a problem with the pituitary gland or the side effect of certain cancer treatments. Name-brand medications that are part of this class include:
In January 2014, the FDA launched a safety review of prescription testosterone products after two studies indicated that the medications might increase the chances that certain men would experience a stroke, heart attack or sudden death:
The FDA completed its review in March 2015, and ordered low-T manufacturers to add new warnings to their product labels regarding a possible association with heart attacks and strokes. The FDA also required that the labeling be modified to clearly state that the drugs hadn’t been proven safe or effective in treating age-related hypogonadism. In doing so, the agency noted that the use of low-T therapy had increased significantly, from 1.3 million patients in 2009 to 2.3 million patients in 2013 receiving a prescription for a testosterone product. The FDA expressed concern that the drugs are being used extensively in attempts to relieve symptoms in men who have low testosterone for no apparent reason other than aging. Read More
Since the FDA issued its alert, thousands of men have filed lawsuits after suffering strokes and other cardiovascular problems that were allegedly caused by AndroGel and other low T therapies. Among other things, these lawsuits accuse the manufacturers of low-therapies of:
There is still time for the alleged victims of testosterone-related strokes to file their own lawsuits against the manufacturers of low-T therapies. To learn more about this growing litigation, please contact our attorneys today, by calling (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.